Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123745 · ClinicalTrials.gov registry record · NA
ivWatch Model 400: Device Validation for Infiltrated Tissues
A NA study, sponsored by ivWatch.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT02123745 is a NA study that has completed, run by ivWatch. The registered enrollment target is 71 participants.
The verdict
NCT02123745, a NA study, has completed, sponsored by ivWatch.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
A single arm trial consisting of 70 adult volunteers to assess the safety and efficacy of the ivWatch Model 400 when observing infiltrated tissues at common sites for peripheral IV therapy.
Interventions
- DEVICE The ivWatch Model 400
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02123745
The ClinicalTrials.gov registry entry for NCT02123745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ivWatch, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The ivWatch Model 400 is the first listed.
NCT02123745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02123745 about?
NCT02123745 is a clinical study titled "ivWatch Model 400: Device Validation for Infiltrated Tissues". A single arm trial consisting of 70 adult volunteers to assess the safety and efficacy of the ivWatch Model 400 when observing infiltrated tissues at common sites for peripheral IV therapy.
What is the current status of trial NCT02123745?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2014-02. Estimated completion is 2014-02.
What interventions are being tested in trial NCT02123745?
The interventions under investigation include: The ivWatch Model 400 (DEVICE).
Who is sponsoring clinical trial NCT02123745?
This trial is sponsored by ivWatch, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.